Manufacturing approach 4.0 for Pharma and Biotech
NETIB 2018 an opportunity to researchers and decision makers in biotechnology to discuss new challenges in R&D, Bioproduction and Business.
This two-day event aims to shed light on new trends and technologies in cell therapy, gene therapy and microbiome for therapeutic approaches.
Thursday 25th of October
9.00 – 9.10
Welcome and Introduction of NETIB2018
Marc Phalippou, General Director,
Bordeaux INP
Brigitte Lindet, Director,
ENSTBB – Bordeaux INP
9.10 – 10.00
Biotech’s travels : from small molecule and biologics to cell therapy and live bacteria – regulatory, operational and strategic consequences
Eric de la Fortelle, Venture Partner,
Seventure
10.00 – 10.30
Cell and Gene-based Approaches : Bridging the Gap Between Potential and Reality
Arsia Amir-Aslani, Program Director GEM,
Grenoble Ecole Management
10.30 – 11.00
State of the art Immuno Therapy
Benoît de Ducla, Global Medical Team Manager,
Roche
11.00 – 11.30
Coffee Break
Job dating session
11.30 – 12.00
New trends in gene therapy
Olivier Negre, Head of Pre-clinical,
Blue Bird Bio
12.00 – 12.30
UCART19, a challenge and opportunity for Servier
Marielle Anger-Leroy, Biotechnology Industrial Development Director, Servier
12.30 – 14.00
Lunch
Job dating session
14.00 – 14.30
New trends in microbiome
Georges Rawadi, CEO,
LNC Therapeutics
14.30 – 15.00
New trends in skin microbiome for dermocosmetics
Maude Brossat, Research scientist natural cosmetic ingredients,
L’Oréal
15.00 – 16.30
Panel discussion
Trends and Business Models in Biotech
Participants :
Zaki Sellam, CEO, Avicenna Oncology
Eric de le Fortelle, Venture Partner, Seventure
Jean-Pascal Zambaux, CEO, Gemacbio
Georges Rawadi, CEO, LNC Therapeutics
Fabien Moncaubeig, CEO, BIP Partners
16.30 – 16.45
Closure of Day 1
16.45 – 19.00
Networking session and drinks
Job dating session
From 20.00
Gala dinner
Friday 26th of October
9.00 – 9.10
Welcome and Introduction of Day 2
9.10 – 9.40
New trends and opportunities in CRISP CAS 9 technologies
Edouard de Dreuzy, Scientist,
Editas Medicine
9.40 – 10.10
Virus production aav/lv for cell/Gene therapy
Bertrand Coissac, Business Director, Polyplus-transfection
10.10 – 10.40
Coffee Break
Job dating session
10.40 – 11.10
Stable and scalable helper virus-free rAAV packaging/producing system based on human cells in suspension.
Simon Fradin, Head of Upstream Process Development,
Cevec
11.10 – 11.40
New trends and opportunities in CAR-T process development
Alexandre Lennaertz, Development Manager,
MaSTherCell
11.40 – 12.10
Marc Meyer, Managing Director, Werum
12.10 – 14.00
Lunch
Job dating session
14.00 – 14.30
Pushing for an industrial revolution in cell therapy manufacturing, from brain to bioreactor
Maxime Feyeux, CEO,
TreeFrog Therapeutics
14.30 – 15.00
A cell therapy approach for liver diseases
Tuan Huy Nguyen, CEO,
GoLiver Therapeutics
15.00 – 15.30
Learning about single use by innovative tools
Matthieu Egloff, Marketing Architect,
Ouat
16.00
Closure of conference